Drug for High Triglycerides Has Sustained Effect at Low Dosages: Baylor College of Medicine
November 21, 2019
November 21, 2019
HOUSTON, Texas, Nov. 21 [TNSmedicalresearch-American Heart Association] -- The Baylor College of Medicine issued the following news release:
A drug therapy targeting the production of a protein produced by the liver has led to sustained and significant reductions in triglyceride levels using low dosages. The findings were recently reported in a late-breaking presentation at the American Heart Association Scientific Sessions 2019 by Dr. Christi Ballantyne, professor of medicine and c . . .
A drug therapy targeting the production of a protein produced by the liver has led to sustained and significant reductions in triglyceride levels using low dosages. The findings were recently reported in a late-breaking presentation at the American Heart Association Scientific Sessions 2019 by Dr. Christi Ballantyne, professor of medicine and c . . .